A new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten disease, directly into the cerebrospinal fluid (CSF) has potential therapeutic effects.
FGF21 hormone drives protein-specific appetite and reward in the brain
When faced with multiple food options and ultimately choosing one, the factors of that decision-making process may be more physiological than previously assumed.
February 25, 2025